Neurosense Therapeutics (NRSN) Earnings Date & Reports

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NRSN is expected to report earnings to fall 61.84% to -78 cents per share on December 02

Neurosense Therapeutics NRSN Stock Earnings Reports

Q3'26

Est.

$-0.79

Q2'26

Beat

by $1.84

Q4'25

Missed

by $0.13

Q3'25

Beat

by $0.02

Q2'25

Beat

by $0.09

The last earnings report on September 25 showed earnings per share of -205 cents, beating the estimate of -390 cents. With 9.45K shares outstanding, the current market capitalization sits at 9.67M.

View a ticker or compare two or three

NRSN

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for NRSN